Downregulation of DEC1 by RNA interference attenuates ischemia/reperfusion‑induced myocardial inflammation by inhibiting the TLR4/NF‑κB signaling pathway

Xu,Weipan; Zhang,Kai; Zhang,Yi; Ma,Shanxue; Jin,Daoqun

doi:10.3892/etm.2020.8706

Downregulation of DEC1 by RNA interference attenuates ischemia/reperfusion‑induced myocardial inflammation by inhibiting the TLR4/NF‑κB signaling pathway

Authors:
- Weipan Xu
- Kai Zhang
- Yi Zhang
- Shanxue Ma
- Daoqun Jin
View Affiliations

Affiliations: Department of Cardiology, Huangshi Central Hospital, Affiliated Hospital of Hubei Polytechnic University, Edong Healthcare Group, Huangshi, Hubei 435000, P.R. China
Published online on: April 30, 2020 https://doi.org/10.3892/etm.2020.8706
Pages: 343-350
Copyright: © Xu et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Inflammation has been implicated in the pathogenesis of myocardial ischemia/reperfusion (I/R) injury (MIRI). Previous studies have confirmed that deleted in esophageal cancer 1 (DEC1) is an important transcription factor in inflammation. However, the role of DEC1 in MIRI remains unclear. The present study aimed to determine whether the downregulation of DEC1 by RNA interference alleviated inflammation to protect against MIRI. Adult Sprague‑Dawley rats (n=48) were randomly divided into four groups: Sham; I/R; adenovirus expressing green fluorescent protein control (Ad‑G‑Control); and DEC1‑targeting RNA interference (Ad‑G‑DEC1) groups. Following gene delivery 4 days later, the rat myocardial I/R model was established and myocardial enzymes [creatine kinase (CK) and lactate dehydrogenase (LDH)] were detected. Hematoxylin and eosin (H&E) staining was performed to evaluate the myocardial damage and the infarct area was assessed using Evans Blue/triphenyltetrazolium chloride staining. The inflammatory mediators interleukin (IL)‑β and tumor necrosis factor (TNF)‑α were also detected using ELISA kits to assess the inflammatory response. Finally, western blotting and reverse transcription‑quantitative PCR were used to analyze the expression levels of associated proteins and mRNAs. Ad‑G‑DEC1 RNA interference markedly decreased DEC1 expression levels. In addition, following the downregulation of DEC1 expression, the infarct size, CK, LDH, Toll‑like receptor (TLR)4, NF‑κB, IL‑β and TNF‑α levels were all significantly decreased. In conclusion, the results of the present study suggested that the downregulation of DEC1 may decrease the inflammation by suppressing the TLR4/NF‑κB signaling pathway, which may represent a therapeutic target for MIRI.

View Figures

View References

1	Nelson CP, Goel A, Butterworth AS, Kanoni S, Webb TR, Marouli E, Zeng L, Ntalla I, Lai FY, Hopewell JC, et al: Association analyses based on false discovery rate implicate new loci for coronary artery disease. Nat Genet. 49:1385–1391. 2017.PubMed/NCBI View Article : Google Scholar
2	Godoy LC, Lawler PR, Farkouh ME, Hersen B, Nicolau JC and Rao V: Urgent revascularization strategies in patients with diabetes mellitus and acute coronary syndrome. Can J Cardiol. 35:993–1001. 2019.PubMed/NCBI View Article : Google Scholar
3	Shen Y, Liu X, Shi J and Wu X: Involvement of Nrf2 in myocardial ischemia and reperfusion injury. Int J Biol Macromol. 125:496–502. 2019.PubMed/NCBI View Article : Google Scholar
4	Wu MY, Yiang GT, Liao WT, Tsai AP, Cheng YL, Cheng PW, Li CY and Li CJ: Current mechanistic concepts in ischemia and reperfusion injury. Cell Physiol Biochem. 46:1650–1667. 2018.PubMed/NCBI View Article : Google Scholar
5	Ruan Z, Wang S, Yu W and Deng F: LncRNA MALAT1 aggravates inflammation response through regulating PTGS2 by targeting miR-26b in myocardial ischemia-reperfusion injury. Int J Cardiol. 288(122)2019.PubMed/NCBI View Article : Google Scholar
6	Yao L, Chen H, Wu Q and Xie K: Hydrogen-rich saline alleviates inflammation and apoptosis in myocardial I/R injury via PINK-mediated autophagy. Int J Mol Med. 44:1048–1062. 2019.PubMed/NCBI View Article : Google Scholar
7	Sato F, Kohsaka A, Bhawal UK and Muragaki Y: Potential roles of Dec and Bmal1 genes in interconnecting circadian clock and energy metabolism. Int J Mol Sci. 19(pii: E781)2018.PubMed/NCBI View Article : Google Scholar
8	Liu Q, Wu Y, Seino H, Haga T, Yoshizawa T, Morohashi S and Kijima H: Correlation between DEC1/DEC2 and epithelial-mesenchymal transition in human prostate cancer PC-3 cells. Mol Med Rep. 18:3859–3865. 2018.PubMed/NCBI View Article : Google Scholar
9	Noshiro M, Kawamoto T, Nakashima A, Ozaki N, Ueno T, Saeki M, Honda K, Fujimoto K and Kato Y: Deficiency of the basic helix-loop-helix transcription factor DEC1 prevents obesity induced by a high-fat diet in mice. Genes Cells, Jul 3, 2018 (Epub ahead of print).
10	Jia Y, Hu R, Li P, Zheng Y, Wang Y and Ma X: DEC1 is required for anti-apoptotic activity of gastric cancer cells under hypoxia by promoting Survivin expression. Gastric Cancer. 21:632–642. 2018.PubMed/NCBI View Article : Google Scholar
11	Camponeschi A, Todi L, Cristofoletti C, Lazzeri C, Carbonari M, Mitrevski M, Marrapodi R, Del Padre M, Fiorilli M, Casato M and Visentini M: DEC1/STRA13 is a key negative regulator of activation-induced proliferation of human B cells highly expressed in anergic cells. Immunol Lett. 198:7–11. 2018.PubMed/NCBI View Article : Google Scholar
12	Zhang F, Suzuki M, Kim IS, Kobayashi R, Hamada N, Sato F and Bhawal UK: Transcription factor DEC1 is required for maximal experimentally induced periodontal inflammation. J Periodontal Res. 53:883–893. 2018.PubMed/NCBI View Article : Google Scholar
13	Martínez-Llordella M, Esensten JH, Lipsky RH, Marini A, Chen J, Mughal M, Mattson MP, Taub DD and Bluestone JA: CD28-inducible transcription factor DEC1 is required for efficient autoreactive CD4+ T cell response. J Exp Med. 210:1603–1619. 2013.PubMed/NCBI View Article : Google Scholar
14	Bhawal UK, Ito Y, Tanimoto K, Sato F, Fujimoto K, Kawamoto T, Sasahira T, Hamada N, Kuniyasu H, Arakawa H, et al: IL-1β-mediated up-regulation of DEC1 in human gingiva cells via the Akt pathway. J Cell Biochem. 113:3246–3253. 2012.PubMed/NCBI View Article : Google Scholar
15	Olkkonen J, Kouri VP, Hynninen J, Konttinen YT and Mandelin J: Differentially expressed in chondrocytes 2 (DEC2) increases the expression of IL-1β and Is abundantly present in synovial membrane in rheumatoid arthritis. PLoS One. 10(e0145279)2015.PubMed/NCBI View Article : Google Scholar
16	Zusso M, Lunardi V, Franceschini D, Pagetta A, Lo R, Stifani S, Frigo AC, Giusti P and Moro S: Ciprofloxacin and levofloxacin attenuate microglia inflammatory response via TLR4/NF-kB pathway. J Neuroinflammation. 16(148)2019.PubMed/NCBI View Article : Google Scholar
17	Rahimifard M, Maqbool F, Moeini-Nodeh S, Niaz K, Abdollahi M, Braidy N, Nabavi SM and Nabavi SF: Targeting the TLR4 signaling pathway by polyphenols: A novel therapeutic strategy for neuroinflammation. Ageing Res Rev. 36:11–19. 2017.PubMed/NCBI View Article : Google Scholar
18	Yuan L, Dai X, Fu H, Sui D, Lin L, Yang L, Zha P, Wang X and Gong G: Vaspin protects rats against myocardial ischemia/reperfusion injury (MIRI) through the TLR4/NF-κB signaling pathway. Eur J Pharmacol. 835:132–139. 2018.PubMed/NCBI View Article : Google Scholar
19	Guo X, Jiang H, Yang J, Chen J, Yang J, Ding JW, Li S, Wu H and Ding HS: Radioprotective 105 kDa protein attenuates ischemia/reperfusion-induced myocardial apoptosis and autophagy by inhibiting the activation of the TLR4/NF-κB signaling pathway in rats. Int J Mol Med. 38:885–893. 2016.PubMed/NCBI View Article : Google Scholar
20	Bayne K: Revised guide for the care and use of laboratory animals available. American physiological society. Physiologist. 39: 199:208–211. 1996.PubMed/NCBI
21	Mittereder N, March KL and Trapnell BC: Evaluation of the concentration and bioactivity of adenovirus vectors for gene therapy. J Virol. 70:7498–7509. 1996.PubMed/NCBI
22	Livak JK and Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.PubMed/NCBI View Article : Google Scholar
23	Yang J, Fan ZX, Yang J, Ding J, Yang C and Chen L: microRNA-22 attenuates myocardial ischemia-reperfusion injury via an anti-inflammatory mechanism in rats. Exp Ther Med. 12:3249–3255. 2016.PubMed/NCBI View Article : Google Scholar
24	Neri M, Riezzo I, Pascale N, Pomara C and Turillazzi E: Ischemia/reperfusion injury following acute myocardial infarction: A critical issue for clinicians and forensic pathologists. Mediators Inflamm. 2017(7018393)2017.PubMed/NCBI View Article : Google Scholar
25	Chorawala MR, Prakash P, Doddapattar P, Jain M, Dhanesha N and Chauhan AK: Deletion of extra domain A of fibronectin reduces acute myocardial ischaemia/reperfusion injury in hyperlipidaemic mice by limiting thrombo-inflammation. Thromb Haemost. 118:1450–1460. 2018.PubMed/NCBI View Article : Google Scholar
26	Hernandez-Resendiz S, Chinda K, Ong SB, Cabrera-Fuentes H, Zazueta C and Hausenloy DJ: The role of redox dysregulation in the inflammatory response to acute myocardial ischaemia-reperfusion injury-adding fuel to the fire. Curr Med Chem. 25:1275–1293. 2018.PubMed/NCBI View Article : Google Scholar
27	Ivanov SV, Salnikow K, Ivanova AV, Bai L and Lerman MI: Hypoxic repression of STAT1 and its downstream genes by a pVHL/HIF-1 target DEC1/STRA13. Oncogene. 26:802–812. 2007.PubMed/NCBI View Article : Google Scholar
28	Knowlton AA: Paying for the tolls: The high cost of the innate immune system for the cardiac myocyte. Adv Exp Med Biol. 1003:17–34. 2017.PubMed/NCBI View Article : Google Scholar
29	Fang Y and Hu J: Toll-like receptor and its roles in myocardial ischemic/reperfusion injury. Med Sci Monit. 17:RA100–RA109. 2011.PubMed/NCBI View Article : Google Scholar
30	Xue J, Ge H, Lin Z, Wang H, Lin W, Liu Y, Wu G, Xia J and Zhao Q: The role of dendritic cells regulated by HMGB1/TLR4 signalling pathway in myocardial ischaemia reperfusion injury. J Cell Mol Med. 23:2849–2862. 2019.PubMed/NCBI View Article : Google Scholar
31	Su Q, Li L, Sun Y, Yang H, Ye Z and Zhao J: Effects of the TLR4/Myd88/NF-κB signaling pathway on NLRP3 inflammasome in coronary microembolization-induced myocardial injury. Cell Physiol Biochem. 47:1497–1508. 2018.PubMed/NCBI View Article : Google Scholar
32	Tang ZH, Peng J, Ren Z, Yang J, Li TT, Li TH, Wang Z, Wei DH, Liu LS, Zheng XL and Jiang ZS: New role of PCSK9 in atherosclerotic inflammation promotion involving the TLR4/NF-κB pathway. Atherosclerosis. 262:113–122. 2017.PubMed/NCBI View Article : Google Scholar
33	Chousterman BG, Swirski FK and Weber GF: Cytokine storm and sepsis disease pathogenesis. Semin Immunopathol. 39:517–528. 2017.PubMed/NCBI View Article : Google Scholar
34	Ma C, Xu Z and Lv H: Low n-6/n-3 PUFA ratio improves inflammation and myocardial ischemic reperfusion injury. Biochem Cell Biol. 97:621–629. 2019.PubMed/NCBI View Article : Google Scholar